Supporting policies that promote innovation in the life sciences
MINNEAPOLIS, Oct. 14, 2011 /PRNewswire-USNewswire/ -- Created to support policies that foster an environment in which medical innovation can thrive, the American Life Sciences Innovation Council (ALSIC) is pleased to announce its board of directors: William Harrison, the President and Chief Executive Officer of VIDA Sciences; Dr. Joseph Dunn, Chief Executive Officer and Director of Research at OmniPharm Research International; H. Dean Hart, Chief Commercial Officer of NanoInk, Inc.; Steve Knuth, Chief Executive Officer at Public Affairs Company; and David Mohler, a leading public policy attorney and consultant to the life sciences industry.
ALSIC will share its research and policy positions with policymakers and encourage its supporters and the general public to communicate their views on these issues at all levels of government. ALSIC will seek the commitment of these policymakers to implement statutes, rules, and regulations consistent with principles supporting life science innovation.
ALSIC will work to educate the public and policymakers about the effects of government regulation on key factors that drive life science innovation: strong intellectual property protection; adequate reimbursement driven by market forces; unfettered collaboration with basic science partners; a transparent and predictable regulatory environment; and access to capital. ALSIC concerns itself with developments in federal, state and international policy affecting the breadth of innovative life sciences including medical devices, biopharmaceuticals, and diagnostics.
SOURCE American Life Sciences Innovation Council